✦ LIBER ✦

Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy

✍ Scribed by Feldman-Stewart, Deb; Madarnas, Yolanda; Mates, Mihaela; Tong, Christine; Grunfeld, Eva; Verma, Shailendra; Carolan, Hannah; Brundage, Michael

Book ID: 123435441
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 278 KB
Volume: 22
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2013.04.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Information needs of post-menopausal wom

Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy

✍ Feldman-Stewart, Deb; Madarnas, Yolanda; Mates, Mihaela; Tong, Christine; Grunfe 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 351 KB

Questioning the Benefit of Adjuvant Endo

Questioning the Benefit of Adjuvant Endocrine Therapy (ET) in Elderly Women With Early-Stage Hormone Receptor Positive (HR+) Breast Cancer Treated With Breast-Conserving Surgery (BCS) and Radiation Therapy (RT)

✍ Murphy, C.; Eastwick, G.; Li, T.; Johnson, M.; Goldstein, L.; Sigurdson, E.; Ble 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Interpreting breast international group

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

✍ Meredith M Regan; Karen N Price; Anita Giobbie-Hurder; Beat Thürlimann; Richard 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 368 KB